Dollinger index

Dan Fillenwarth:

• Led a team that effectively doubled the
  capacity of the EBPVD Praxair
  Surface Technologies plant in Indiana
  over the past four years.


• Implemented a series of engineering
  improvements to equipment in the
  plant that have increased output of
  current capital by 30 percent..


• Created and implemented a scheduling
  program that significantly improved
  communications throughout a 24/7
  operation.

Sri Sampath:

• Developed a new design for a baby-
  care product that would combine the
  features of different products.
  Currently under prototype develop-
  ment.


• Developed conceptual design of a new
  exercise/therapy product for foot mas-

sage/exercise based on Asian therapeu-

tic techniques.

• Developed conceptual design for a
  hair-care appliance.


• Partly financed several entrepreneurial
  ventures. One of the ventures was in
  the production of a mass-media prod-
  uct in India. Financed two other ven-
  tures in information technology devel-
  opment for the health-care industry.
  Of these two, one is an information-
  technology consulting firm in India
  that specializes in products and appli-
  cations in medical-imaging technolo-
  gy. The other provides services to the
  health-care industry.


• Cofounded a community organization
  of volunteers to share Indian cultural
  heritage with local elementary school
  kids. This organization is currently
  evaluating proposals for creating a ven-
  ture to build a local gathering place.

MedTrack 437

Operating activities
Net income
Depreciation
Accounts Receivable
Inventories
Accounts Payable
Deferred Income Taxes
Total operating activities

Investing activities
Capital expenditures
Other investing cash flow items
Total investing activities

Financing activities
Long-term debt/financing
Preferred stock
Total cash dividends paid
Common stock
Other financing cash flow items

Total financing activies

Cumulative cash flow
Beginning cash balance
Ending cash balance

Year 1

($1,810)

5

(250)

(20)

895

(776)

($1,955)

($75)

0

($75)

$ 4,000

0

0

0

0

Year 2

($1,135)

50

(1,815)

(145)

1,443

(487)

($2,089)

($750)

0

($750)

($480)

0

0

0

0

Year 3

$6,483

87

(4,810)

(385)

2,079

1,262

$4,718

($1,309)

0

($1,309)

($480)

0

0

0

0

Year 4

$17,344

175

(8,948)

(716)

5,047

0

$12,902

($2,620)

0

($2,620)

($480)

0

0

0

0

Year 5

$32,678

329

(13,196)

(1,056)

7,681

0

$26,436

($4,936)

0

($4,936)

($4,480)

0

0

0

0

Total

$53,560

646

(29,019)

(2,321)

17,146

0

$40,012

($9,690)

0

($9,690)

($1,920)

0

0

0

0

EXHIBIT 9 Pro Forma Cash Flow for MedTrack (U.S. $000’s)

$ 4,000

$ 1,970

6,000

$ 7,970

($480)

($3,319)

7,970

$4,651

($480)

$2,929

4,651

$7,579

($480)

$9,802

7,579

$17,382

($4,480)

$17,020

17,382

$34,402

($1,920)

$28,402